Anzeige
Mehr »
Login
Sonntag, 25.02.2024 Börsentäglich über 12.000 News von 683 internationalen Medien
Nurexone Biologic: Fallen nächste Woche alle Rekorde?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 890952 | ISIN: AU000000CSL8 | Ticker-Symbol: CSJ
Tradegate
23.02.24
21:17 Uhr
172,10 Euro
-0,80
-0,46 %
Branche
Biotechnologie
Aktienmarkt
S&P/ASX 50
1-Jahres-Chart
CSL LIMITED Chart 1 Jahr
5-Tage-Chart
CSL LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
171,20174,7024.02.
172,00173,7023.02.

Aktuelle News zur CSL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrTravere Therapeutics, Inc.: Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy2
FrCSL Vifor: Sparsentan Receives Positive CHMP Opinion For Treatment Of IgA Nephropathy324CANBERA (dpa-AFX) - CSL Vifor and Travere Therapeutics Inc. (TVTX) said that the European Medicines Agency's or EMA CHMP has recommended approval of sparsentan for the treatment of adults with...
► Artikel lesen
FrVifor International AG (CSL Vifor): CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy116Committee for Medicinal Products for Human Use (CHMP) recommends approval of the conditional marketing authorization (CMA) for sparsentan for the treatment of IgA nephropathy (IgAN) in Europe Positive...
► Artikel lesen
FrCSL LIMITED: Change of Director's Interest Notice3
DoGenezen Licenses Cytegrity Stable Lentivirus Production System from CSL2
MiCSL LIMITED: Notification regarding unquoted securities - CSL-
MiGenezen to license CSL's lentiviral vector production system2
DiWhat is the dividend growth rate of CSL stock?3
18.02.Confessions of a Day Trader: Dear CSL, sorry I know it's Valentine's Day but I have a new lover. Or two…4
18.02.Dr Boreham's Crucible: Don't have a heart attack, CSL's profit-making ability is in the blood4
16.02.ScoPo's Powerplays: ASX health stocks tumble as CSL bleeds after Phase III trial misses endpoint2
16.02.CSL LIMITED: Change of Director's Interest Notice1
16.02.CSL LIMITED: Notification regarding unquoted securities - CSL1
15.02.ABIONYX Pharma Acknowledges the Clinical Results of the Phase 3 AEGIS-II Study Evaluating the Efficacy and Safety of CSL Behring's Human-plasma-derived apoA-I, CSL112293Access here the full press release ABIONYX Pharma, (FR0012616852 ABNX PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies...
► Artikel lesen
15.02.ABIONYX Pharma Acknowledges the Clinical Results of the Phase 3 AEGIS-II Study Evaluating the Efficacy and Safety of CSL Behring's Human-plasma-derived apoA-I, CSL112226Regulatory News: ABIONYX Pharma, (FR0012616852 ABNX PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies based on the world's...
► Artikel lesen
14.02.After Vifor buyout, CSL CEO sees 'dampened' outlook for the unit as hurdles mount5
13.02.Earnings call: CSL Limited reports robust H1 FY2024 financial growth8
13.02.Failed drug trial overshadows CSL's bumper profits9
13.02.CSL Limited: Half year reported NPATA US$2 billion¹,² Up 13% at constant currency³475Strong CSL Behring portfolio growth especially Ig FINANCIAL HIGHLIGHTS4 Revenue $8.05 billion, up 11% at CC3NPAT $1.90 billion1, up 17%NPAT $1.94 billion1 at CC3, up 20%NPATA $2.02...
► Artikel lesen
13.02.Everything you need to know about the supersized CSL dividend4
Seite:  Weiter >>
178 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1